| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Cardiothoracic Unit, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
Malignant pleural effusion is a common condition and often presents a challenge for treatment. We report our experience from a single institution with the use of video-assisted thoracoscopic surgery (VATS) in the management of malignant effusions. From September 1992 to April 1995, 69 patients (31 men, 38 women; age range, 38 to 76 years) underwent diagnosis and/or treatment of malignant effusions; these included 46 pleural biopsies, 34 talc insufflations, and 16 limited decortications. There was no mortality and there were no intraoperative complications. Postoperative complications occurred in seven patients (10%). Specific histologic diagnoses were obtained in all but 6 patients (87%). Malignant effusion was confirmed in 25 of 46 cases (54%). Thoracoscopic talc insufflation with or without additional decortication was successful in 32 of 34 cases (94%) in controlling recurrence of effusion after a mean follow-up of 6 months among the survivors (22 patients died during the follow-up period without effusion reaccumulation). We conclude that VATS not only provides an accurate diagnosis but also allows effective therapeutic procedures to be performed for malignant effusions that are associated with an acceptable morbidity.
Key Words: malignant pleural effusion • thoracoscopic talc insufflation • video-assisted thoracoscopy surgery
Submitted on July 31, 1995
Accepted on November 17, 2007
This article has been cited by other articles:
|
|
 |
|
  A Medford and N Maskell Pleural effusion Postgrad. Med. J., November 1, 2005; 81(961): 702 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kolschmann, A. Ballin, and A. Gillissen Clinical Efficacy and Safety of Thoracoscopic Talc Pleurodesis in Malignant Pleural Effusions Chest, September 1, 2005; 128(3): 1431 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir Diagnostic implications of telomerase activity in pleural effusions Eur. Respir. J., September 1, 2003; 22(3): 422 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]
|
|
|
|
|
|
G ANTUNES and E NEVILLE Management of malignant pleural effusions Thorax, December 1, 2000; 55(12): 981 - 983. [Full Text]
|
|
|
|
 |
|
 E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis Radiology, January 1, 1999; 210(1): 277 - 281. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. P. C. Yim, A. T. C. Chan, T. W. Lee, I. Y. P. Wan, and J. K. S. Ho Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1655 - 1658. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
